Further delineation of the SOX18-related Hypotrichosis, Lymphedema, Telangiectasia syndrome (HTLS)

Irene Valenzuela, Paula Fernández-Alvarez, Alberto Plaja, Gema Ariceta, Anna Sabaté-Rotés, Elena García-Arumí, Teresa Vendrell, Eduardo Tizzano

Research output: Contribution to journalArticleResearchpeer-review

8 Citations (Scopus)


© 2018 Elsevier Masson SAS The transcription factor SOX18 has been shown to play a role in the development of hair, blood and lymphatic vessels. Mutations in SOX18 result in hereditary lymphedema, with the unique clinical association of hypotrichosis and telangiectasia (HLTS). Some patients present with additional disease features which may be explained by the location of SOX18 mutation. We report a patient with hypotrichosis-lymphedema-telangiectasia syndrome (HLTS) confirmed by detection of a novel mutation in the SOX18 gene. Few cases of HTLS have been reported in the literature. We reviewed all cases reported to date to delineate the clinical manifestations that allow us to prompt diagnosis of this syndrome for appropriate management and genetic counseling.
Original languageEnglish
Pages (from-to)269-272
JournalEuropean Journal of Medical Genetics
Issue number5
Publication statusPublished - 1 May 2018


  • C3 glomerulonephritis
  • Hypotrichosis
  • Lymphedema
  • SOX18
  • Telangiectasia


Dive into the research topics of 'Further delineation of the SOX18-related Hypotrichosis, Lymphedema, Telangiectasia syndrome (HTLS)'. Together they form a unique fingerprint.

Cite this